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Abstract
Background—Few epidemiologic population-based data are available to describe the wide range 
of health conditions that affect children with asthma. We conducted this study to identify common 
comorbidities of asthma during childhood and compare the prevalences of selected comorbidities 
among children with and without asthma.
Methods—We analyzed weighted data from the 2012 National Health Interview Survey child 
sample, a sample of 10,954 U.S. children aged 3–17 years. Information about each child's health, 
including history of asthma and other health conditions, was provided by an adult proxy 
respondent. We conducted binomial regression to compare the prevalences of 41 selected health 
conditions among children with and without current asthma.
Results—An estimated 10.4% of children aged 3–17 years (n = 1202) were identified as having 
current asthma. Nearly all conditions considered were more common among children with than 
without asthma. Compared to children without asthma, children with asthma had higher 
prevalences of hay fever or respiratory allergies (prevalence difference [PD]: 30.5%; 95% CI: 26.6, 
34.4), eczema or skin allergies (PD: 14.1%; 95% CI: 10.7, 17.5), sinusitis (PD: 11.3%; 95% CI: 
8.4, 14.1), food or digestive allergies (PD: 10.4%; 95% CI: 7.7, 13.1), and difficulty with 
emotions, concentration, behavior, or getting along (PD: 7.9%; 95% CI: 4.7, 11.1).
Conclusions—These results highlight the burden of comorbidities among children with asthma. 
Improved understanding of the impact of comorbidities among children with asthma may help 
develop best practices for the assessment, treatment, and control of coexisting health conditions.
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Children with asthma can be affected by other chronic health conditions [1] and the medical 
management of multiple chronic conditions, including asthma, poses a unique challenge 
[2,3]. Among children with asthma, recognizing and treating comorbid conditions may lead 
to improved asthma outcomes [4]. To date, however, little information is available to inform 
clinical practice and the research community about the wide range of comorbidities affecting 
children with asthma and the potential influences they might have on levels of asthma 
control [2]. Reviews of common comorbidities of asthma have summarized co-occurrence of 
asthma with allergic rhinitis, anxiety and depressive disorders, atopic dermatitis, chronic 
sinusitis, diabetes mellitus, gastroesophageal reflux, hormonal disorders, obesity, obstructive 
sleep apnea, respiratory viral infections, and severe reactions to food allergens [2,5,6]. 
However, data with which to describe the prevalences of specific comorbidities of asthma 
among children are sparse.
In an evaluation of asthma comorbidities among low-income children aged 2–17 years in the 
United States using medical claims data, the most common comorbidity among children 
with asthma was allergic rhinitis [7]. Another recent investigation of conditions among 
children with asthma aged 0–17 years in the United States identified elevated prevalences of 
all conditions considered (cerebral palsy, muscular dystrophy, sickle cell anemia, autism, 
diabetes, arthritis, congenital heart disease, other heart conditions, and hypertension) as well 
as elevated associations of asthma attacks and emergency department visits for asthma with 
increasing numbers of additional comorbid conditions [1]. Despite recent data reporting a 
nearly 10% prevalence of current asthma among children [8] and the growing body of 
evidence that comorbid conditions may affect asthma outcomes among children [1], few 
epidemiologic population-based data are available to describe the overlap of asthma with a 
wider range of chronic health conditions affecting children. In this study, we evaluated data 
collected from a representative sample of U.S. children and examined a broad range of self-
reported medical conditions to identify common comorbidities of asthma during childhood 
and to compare the prevalences of selected comorbidities among children with and without 
asthma.
2. Methods
2.1. National Health Interview Survey
To identify common comorbidities of asthma during childhood, we examined data from the 
2012 National Health Interview Survey (NHIS) child dataset. NHIS is a cross-sectional 
household interview survey conducted annually in the United States using a multistage 
cluster sample design [9]. For each surveyed family in which a child is present in the 
household, one sample child is randomly selected and information about the sample child is 
collected from the sample adult (i.e., the proxy respondent). Additional information about 
the survey methods is available elsewhere [9,10]. In 2012, the NHIS child sample included 
information about 13,275 boys and girls aged 0–17 years. Supplemental health outcome 
questionnaires (e.g., child communication disorders questionnaire and child balance 
questionnaire) were added to the 2012 NHIS for children aged 3 years and older only [11], 
therefore, we limited our analysis to children aged 3 years and older.
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2.2. Identification of current asthma and selected comorbidities
We categorized each child's current asthma status using his/her proxy respondent's responses 
to two questionnaire items: (1) has a doctor or other health professional ever told you that 
[the child] had asthma? and, if yes, (2) does [the child] still have asthma?
Initially, we selected comorbidities based solely on their inclusion in the 2012 NHIS child 
survey questionnaire. Due to unstable estimates for conditions experienced by few children 
with or without asthma, we opted not to evaluate the prevalences of several uncommon 
health conditions (e.g., cystic fibrosis, Down syndrome, muscular dystrophy) included in the 
survey and present results for the remaining conditions, identified as “selected health 
conditions”. For each of the selected health conditions considered, we categorized 
uninformative responses (e.g., refused, don't know) as negative.
2.3. Health consequences of asthma and comorbidities
To evaluate health consequences of asthma and comorbidities, we considered the following 
five outcomes: (1) an asthma attack or episode in the past 12 months; (2) an emergency 
department or urgent care center visit due to asthma in the past 12 months; (3) taking 
prescription medication for ≥3 months in the past 12 months; (4) a medical specialist 
encounter in the past 12 months; and (5) a general practitioner encounter in the past 12 
months. Questionnaire items about prescription medication, medical specialist encounters, 
and general practitioner encounters did not specifically refer to asthma, and are interpreted 
here as medication use or encounters, respectively, for any condition.
2.4. Statistical analysis
Because the NHIS is conducted using a multistage probability design [12], data collected 
about the children (hereafter referred to as the “sample”) are representative of a larger 
population of children in the United States. Weights provided with the data were applied 
during analysis so that the results generated are representative of a weighted estimate of the 
U.S. population of children aged 3–17 years (hereafter referred to as the “weighted 
population estimate”).
First, we conducted descriptive analyses to summarize the demographic characteristics of 
the sample of children and the weighted population estimate. We then evaluated the 
prevalences of selected health conditions among children with and without current asthma. 
Prevalences are presented as percentages, with 95% confidence intervals (CIs), of the 
weighted population estimates of children with and without current asthma separately.
To evaluate associations between prevalences of selected health conditions among children 
with and without current asthma, we used binomial regression models specified with an 
identity link. Standard errors (SEs) were generated by adapting a two-stage approach 
developed by Natarajan et al. [13] to generate robust variance estimates fitting the binomial 
error distribution of our data. Briefly described, in stage 1 we obtained regression parameter 
estimates using weighted linear regression models; specifically, we used SAS proc genmod 
(SAS Institute Inc., Cary, North Carolina, USA). We then used the predicted means and 
linear predictors generated by the weighted linear regression models to convert the 
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covariates and outcomes to “pseudo-covariates” and “pseudo-outcomes” [13] for each 
observation, which were then used in stage 2 to estimate valid standard errors using SAS 
proc surveyreg. Methodologic details, including code for programming in SAS, have been 
published by Natarajan et al. (2008) [13]. We adjusted our models for age category (3–4, 5–
9, 10–14, 15–17 years), Hispanic ethnicity, parental educational attainment (high school 
degree/equivalency or less, some college/associate's degree, bachelor's degree or higher), 
race (white only, black/African-American only, other race only, multiple races), and sex. 
Parental educational attainment, included as an indicator of socio-economic status, was 
assigned as the higher of the mother's and father's educational attainment. Adjusted 
associations are presented as prevalence differences (PDs), which are interpreted as the 
differences between the prevalences of each selected health condition among children with 
current asthma and children without current asthma.
For each child, we computed the total number of positive responses out of the 41 health 
conditions, excluding asthma, in our analysis. We then categorized this total as 0, 1, 2, 3, 4 
and 5 or more health conditions and used this categorization to evaluate health consequences 
of asthma and increasing numbers of comorbidities. Among children with current asthma, 
we estimated the percentages of children for whom the following two outcomes were 
reported: (1) an asthma attack or episode in the past 12 months; (2) an emergency 
department or urgent care center visit due to asthma in the past 12 months. We estimated 
percentages of both outcomes across categories of the total number of other health 
conditions (i.e., 0, 1, 2, 3, 4, and 5 or more). We then generated PDs, with 95% CIs, to 
contrast the prevalences of each outcome among children with one or more of the selected 
comorbidities to the prevalences of each outcome among children with none of the selected 
comorbidities. For the remaining three health consequences (taking prescription medication 
for ≥3 months in the past 12 months, a medical specialist encounter in the past 12 months, 
and a general practitioner encounter in the past 12 months), we contrasted the prevalences of 
each outcome among children with asthma to those among children without asthma across 
categories of selected comorbidities. Comparisons of these three outcomes are also 
presented as PDs, with 95% CIs.
Following our main analysis, for each health condition with a prevalence of 10% or higher 
among children with current asthma, we evaluated associations with current asthma across 
categories of age, race, and sex. We also conducted a sensitivity analysis to evaluate the 
impact of including in our analysis children younger than five years of age, a population in 
which asthma may be difficult to diagnose. In this analysis, we evaluated associations 
between current asthma and each of the selected comorbidities in the sample of children 
aged 5–17 years.
All analyses were conducted using SAS version 9.3 (SAS Institute Inc., Cary, North 
Carolina, USA). Results based on fewer than 50 unweighted respondents (i.e., percentages 
based upon a denominator <50) or for which the relative SE, computed as the SE of the 
percentage divided by the percentage, is >30% are not reported or interpreted. The analyses 
presented here were exempted from institutional review board review by the Centers for 
Disease Control and Prevention.
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The 2012 NHIS child sample included information about 13,275 boys and girls aged 0–17 
years. After excluding children aged 0–2 years (n = 2321; 16%), we analyzed a final study 
population of 10,954 children, estimated to represent over 61.6 million children aged 3–17 
years in the United States. Of the 10,954 children in our final sample, 9133 (84.1%) were 
categorized as never having had asthma and 619 (5.5%) were categorized as ever, but not 
still, having asthma; 1202 (10.4%) were categorized as still having asthma, rendering our 
final categorization of current asthma as no (n = 9752; 89.6%) versus yes (n = 1202; 10.4%) 
(Table 1). The estimated prevalence of current asthma increased across categories of age 
from 7.9% among children aged 3–4 years to 11.3% among children 14–17 years of age. 
The average ages of children with and without current asthma were similar (10.3 and 10.0 
years, respectively). Overall, 67.3% of children were identified as having one or more of the 
41 selected other health conditions, with the percentages also increasing across categories of 
age from 52.5% among children aged 3–4 years to 73.9% among children 14–17 years of 
age. The average age of children with one or more of the selected health conditions was one 
year older than that of children without any of the conditions (10.4 and 9.4 years, 
respectively). Among children with current asthma, 87.8% (95% CI: 85.7, 90.0) had one or 
more of the selected health conditions, compared to 65.0% (95% CI: 63.6, 66.4) among 
children without current asthma. The distribution of the total number of selected health 
conditions per child ranged from 0 to 28 (mean: 4.1; 95% CI: 3.8, 4.4) among children with 
asthma and 0 to 21 (mean: 2.0; 95% CI: 1.9, 2.0) among children without asthma.
Percentages of the weighted population estimates of children with each of the selected health 
conditions are presented in Table 2. While all conditions were more common among 
children with than without current asthma, the most notable adjusted differences occurred in 
the prevalences of hay fever or respiratory allergies (PD: 30.5%; 95% CI: 26.6, 34.4), 
eczema or skin allergies (PD: 14.1%; 95% CI: 10.7, 17.5), sinusitis (PD: 11.3%; 95% CI: 
8.4, 14.1), food or digestive allergies (PD: 10.4%; 95% CI: 7.7, 13.1), difficulty with 
emotions, concentration, behavior, or getting along (PD: 7.9%; 95% CI: 4.7, 11.1), and 
fatigue or lack of energy ≥3 days (PD: 7.8%; 95% CI: 5.2, 10.3). Indeed, for all conditions 
shown in Table 3, adjusted differences in the prevalences of the weighted population 
estimates of children with and without asthma were statistically significant at α = 0.05, with 
the exception of differences in prevalences with autism.
Among children with asthma, percentages with a reported asthma attack in the past 12 
months increased from 40.3% (95% CI: 31.8, 48.7) among children with no comorbidities to 
68.2% (95% CI: 62.5, 74.0) among children with five or more comorbidities (adjusted PD: 
29.2%; 95% CI: 19.1, 39.2) (Table 3). Similarly, among children with asthma, percentages 
with a reported emergency department or urgent care center visit due to asthma in the past 
12 months increased from 11.5% (95% CI: 6.4, 16.5) among children with no comorbidities 
to 26.1% (95% CI: 6.4, 16.5) among children with five or more reported comorbidities 
(adjusted PD: 15.8%; 95% CI: 9.9, 21.6).
Percentages of weighted population estimates of children with several functional 
consequences of asthma across categories of the number of comorbidities reported and by 
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current asthma status are shown in Fig. 1. Across categories of comorbidities, percentages of 
children taking prescription medication for ≥3 months in the past 12 months and percentages 
of children who had an encounter with a medical specialist in the past 12 months (panels A 
and B, respectively) were consistently higher among children with current asthma than 
among those without current asthma. In contrast, no differences were observed in the 
percentages of children with than without current asthma who had seen or talked to a general 
practitioner in the past 12 months (panel C). As indicated by the PDs shown in the bottom 
panels of Fig. 1, there was little variation in the prevalences of each of the three outcomes 
with increasing numbers of comorbidities.
Overall, 15 conditions with prevalences >10% in the weighted population estimate of 
children with current asthma were identified. Analyses conducted across strata of age 
category, race, and sex did not reveal notable difference in the measures of association 
across these demographic categories (not shown). Results of our sensitivity analysis, in 
which we limited our analysis to children aged 5–17, were largely similar to our main results 
(not shown). In these analyses, the prevalences of current asthma and reporting any of the 
selected health conditions were 10.7% (SE: 0.4) and 69.6% (SE: 0.7), respectively, 
compared to 10.4% (SE: 0.4) and 67.3% (SE: 0.7), in our main analysis. Adjusted 
differences in the prevalences of hay fever or respiratory allergies (PD: 30.1%; 95% CI: 
26.2, 34.0), eczema or skin allergies (PD: 13.6%; 95% CI: 10.1, 17.1), sinusitis (PD: 12.3%; 
95% CI: 9.2, 15.4), food or digestive allergies (PD: 10.9%; 95% CI: 8.0, 13.9), difficulty 
with emotions, concentration, behavior, or getting along (PD: 9.8%; 95% CI: 6.2, 13.3), and 
fatigue or lack of energy ≥3 days (PD: 8.3%; 95% CI: 5.5, 11.0) were similar in magnitude 
and precision to those generated in our main analysis.
4. Discussion
We conducted this study to describe the prevalence of selected chronic health conditions 
among children in the United States and found higher prevalences of conditions among 
children with asthma than among children without asthma. Among all children, percentages 
of children taking prescription medication for any reason and with a reported visit to a 
medical specialist for any reason were consistently higher among children with than without 
asthma. Among children with asthma, we found increasing prevalences of asthma attacks 
and emergency department visits with increasing numbers of comorbid conditions.
Our findings support and extend our understanding about the burden of multiple chronic 
health conditions, including allergic conditions [7] and anxiety and depressive disorders 
[14], on children with asthma. Most notably, our analysis took advantage of the wide range 
of comorbidities included in the 2012 NHIS survey to present prevalences of comorbidities 
experienced in the past 12 months. Our work complements that of Patel et al., who examined 
NHIS data from 2007 to 2012 to evaluate the prevalences of nine chronic conditions in 
children with and without asthma [1]. The conditions reported by Patel et al. were all were 
relatively rare and were all more common among children with asthma than children without 
asthma [1]. Though limited to a single year of the NHIS, our analysis included a 
comprehensive list of comorbidities in order to investigate the extent to which children with 
asthma may be affected by other, more common, conditions.
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Children with multiple comorbid conditions of asthma may be taking medications for these 
conditions, increasing the potential for interactions between medications or confusion about 
the roles of medications. Children with multiple chronic illnesses may also be more likely to 
receive care from multiple providers, potentially making their asthma management 
fragmented and less effective. The finding of increased prevalences of health conditions less 
likely to have common, proximal etiologic origins suggests that relationships between 
asthma and these common comorbidities should be considered carefully. One possible 
explanation for the overlap includes that children with asthma may be more susceptible to, 
or more likely to be diagnosed with other chronic conditions, such as recurrent respiratory 
viral infections. Another possibility is that asthma or its treatment may directly cause or 
contribute to other chronic conditions. For example, prolonged systemic glucocorticoid use 
may affect blood pressure, glucose metabolism, sleep, and other health outcomes, while the 
use of beta agonists may induce increased heart rate and tremor [15–17]. Children with 
chronic conditions may be more susceptible to asthma due to shared mechanistic pathways, 
such as chronic inflammation [18,19]. If children with at least one medical condition are 
more likely to seek medical care, they may have more opportunities to have other chronic 
medical conditions diagnosed. And some children may be simultaneously susceptible to 
asthma and other health conditions for reasons not yet fully understood. Excluding a bias in 
the reporting of multiple chronic conditions, improvements in our understanding of the 
temporal and causal relationships between asthma and other chronic health conditions may 
inform strategies for the management of asthma.
The NHIS is a questionnaire-based survey and does not include validation of responses or 
measures of the severity or control of asthma or any of the other selected health conditions 
included in our analysis. This limitation is counterbalanced by the large number of children 
in the survey and the wide geographic distribution of the sample. Our results are robust to 
the exclusion of children younger than five years of age, suggesting that challenges in 
diagnosing asthma among children under the age of five do not noticeably influence our 
estimates. While many of the conditions identified in this analysis as co-occurring with 
asthma in children likely share atopic etiologies (e.g., eczema, hay fever) with asthma, we 
cannot definitively identify these conditions as atopic without confirmation by allergy 
testing. Our findings of positive associations of the number of comorbidities with asthma 
attacks and emergency department or urgent care visits suggest that multiple comorbid 
conditions may be a risk factor for loss of asthma control. Our investigation was unable to 
determine whether these relationships might be attributable to intrinsic characteristics of 
children or modifiable factors such as limited time in a clinical visit to assess asthma control.
5. Conclusions
Our findings extend previous evidence that additional chronic health conditions are more 
common among children with than without asthma by presenting estimates of the burden of 
a wide range of health conditions, prevalences of asthma attacks and asthma-related 
emergency department visits, and metrics of health care utilization. Overall, these results 
highlight the importance of considering medical comorbidities when treating children with 
asthma and they may be useful for improved understanding of the simultaneous management 
of asthma and other health conditions among children aged 3–17 years. Improving our 
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understanding of the burden of comorbidities among children with asthma may help develop 
best practices for the assessment, treatment, and control of childhood asthma.
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Percentages of the weighted population estimate of children taking prescription medication 
for ≥3 months in the past 12 months (panel A, top), with a medical specialist encounter in 
the past 12 months (panel B, top), and with a general practitioner encounter within the past 
12 months (panel C, top) among children with and without current asthma and associations 
between asthma and each outcome across categories of the number of comorbidities (panels 
A–C, bottom). Associations are adjusted for age, Hispanic ethnicity, parental educational 
attainment, race, and sex.
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Table 1
Characteristics of the study sample and percentages of the weighted population estimate with current asthma 
and with any selected health conditions excluding asthma.




a Percent (95% CI) Percent (95% CI) Percent (95% CI)
Total 10,954 61,696 100. 10.4 (9.6, 11.1) 67.3 (66.0, 68.6)
Age, in years
    3–4 1473 8040 13.0 (12.2, 13.9) 7.9 (6.1, 9.7) 52.5 (49.2, 55.8)
    5–9 3441 20,512 33.2 (32.1, 34.4) 10.6 (9.2, 11.9) 66.9 (64.8, 69.0)
    10–14 3562 20,695 33.5 (32.4, 34.7) 10.5 (9.3, 11.7) 69.6 (67.6, 71.5)
    14–17 2478 12,448 20.2 (19.2, 21.1) 11.3 (9.7, 12.9) 73.9 (71.7, 76.1)
Asthma history
    Current 1202 6389 10.4 (9.6, 11.1) 100.0 87.8 (85.7, 90.0)
    Former 619 3391 5.5 (5.0, 6.0) 0.0 80.4 (76.5, 84.2)
    Never 9133 51,915 84.1 (83.3, 85.0) 0.0 64.0 (62.5, 65.4)
Hispanic ethnicity
    No 7780 47,093 76.3 (75.1, 77.5) 10.5 (9.7, 11.3) 69.6 (68.1, 71.2)
    Yes 3174 14,602 23.7 (22.5, 24.9) 10.0 (8.5, 11.5) 59.9 (57.7, 62.1)
No. selected health conditions
b
    0 3531 20,157 32.7 (31.4, 34.0) 3.9 (3.1, 4.6) 0.0
    1 2437 13,524 21.9 (20.9, 22.9) 8.0 (6.7, 9.4) 100.0
    2 1595 8779 14.2 (13.4, 15.0) 9.5 (7.6, 11.5) 100.0
    3 1021 5824 9.4 (8.8, 10.1) 13.7 (11.2, 16.2) 100.0
    4 684 3762 6.1 (5.5, 6.7) 18.4 (14.4, 22.4) 100.0
    5+ 1686 9649 15.6 (14.8, 16.5) 22.8 (20.3, 25.3) 100.0
Parental education
    High school degree or less 4182 21,267 34.5 (33.0, 35.9) 11.8 (10.5, 13.0) 63.7 (61.6, 65.7)
    Some college 3397 19,159 31.1 (29.8, 32.3) 11.6 (10.3, 13.0) 70.7 (68.7, 72.8)
    Bachelor's degree or higher 3375 21,269 34.5 (33.0, 36.0) 7.8 (6.7, 8.9) 67.9 (65.6, 70.2)
Race
    Black/African-American only 1796 8761 14.2 (13.3, 15.1) 17.7 (15.6, 19.8) 67.8 (66.3, 69.2)
    White only 7689 46,032 74.6 (73.4, 75.8) 9.0 (8.1, 9.8) 66.7 (63.5, 69.8)
    Other
c
 only
861 3857 6.3 (5.6, 6.9) 8.5 (5.4, 11.6) 72.7 (67.8, 77.5)
    Multiple race 608 3046 4.9 (4.4, 5.5) 12.6 (9.2, 16.0) 59.6 (55.4, 63.8)
Sex
    Female 5382 30,182 48.9 (47.8, 50.1) 9.7 (8.7, 10.7) 65.4 (63.6, 67.2)
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Includes American Indian, Alaska Native, Asian, and other race groups not identified.
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Table 2
Percentages of the weighted population estimate of children with selected health conditions by asthma history.
Current asthma PD (95% Cl)
a
Yes No
Sample children Weighted population estimate Sample children Weighted population estimate
No. Percent (95% CI) No. Percent (95% CI)
Allergies
    Eczema/skin allergy
b 303 24.8 (21.4, 28.3) 989 10.1 (9.3, 10.9) 14.1 (10.7, 17.5)
    Food/digestive allergy
b 166 15.0 (12.2, 17.7) 416 4.4 (3.9, 5.0) 10.4 (7.7, 13.1)
    Hay fever/respiratory allergy
b 521 45.2 (41.4, 49.1) 1481 15.2 (14.2, 16.2) 30.5 (26.6, 34.4)
Cardiovascular or metabolic
    Congenital heart disease or other 
heart condition
27 2.4 (1.2, 3.6) 102 1.1 (0.8, 1.4) 1.4 (0.3, 2.4)
    High cholesterol
b 18 1.4 (0.6, 2.2) 78 0.7 (0.5, 0.9) 0.7 (0.005, 1.3)
    Hypertension
b 23 2.1 (1.0, 3.1) 60 0.7 (0.4, 0.9) 1.1 (0.3, 2.0)
    Overweight
b 129 9.9 (7.9, 12.0) 544 4.9 (4.4, 5.4) 4.0 (2.2, 5.9)
Gastrointestinal
    Abdominal pain
b 142 10.4 (8.5, 12.4) 586 5.9 (5.3, 6.4) 3.9 (2.0, 5.8)
    Constipation requiring medication
b 87 6.5 (4.7, 8.3) 244 2.7 (2.3, 3.1) 3.9 (2.0, 5.7)
    Diarrhea/colitis
b 28 1.8 (0.9, 2.7) 116 1.2 (0.9, 1.5) 0.9 (0.02, 1.8)
Hearing
    Trouble hearing or deaf without a 
hearing aid
66 6.8 (4.5, 9.1) 188 2.0 (1.6, 2.3) 4.6 (2.4, 6.9)
Infectious
    Ear infections, ≥3 in the past 3 
months
106 9.2 (6.8, 11.6) 381 3.8 (3.4, 4.3) 5.0 (2.8, 7.2)
    Influenza or pneumonia
b 129 10.6 (8.4, 12.9) 457 4.6 (4.1, 5.2) 6.0 (3.9, 8.2)
    Sinusitis
b 197 18.0 (15.0, 20.9) 573 6.1 (5.5, 6.8) 11.3 (8.4, 14.1)
    Strep or tonsillitis
b 208 18.4 (15.0, 21.9) 1,110 12.3 (11.3, 13.2) 6.3 (2.6, 10.1)
    Sore throat other than strep or 
tonsillitis
b
297 25.2 (21.7, 28.7) 1,779 18.6 (17.6, 19.6) 7.2 (3.6, 10.7)
Mood-related
    Depression
b 77 6.6 (4.7, 8.5) 261 2.5 (2.1, 2.8) 3.4 (1.8, 5.1)
    Difficulty with emotions, 
concentration, behavior, or getting 
along
c
321 26.9 (23.6, 30.2) 1,608 16.9 (15.9, 17.9)
7.9 (4.7, 11.1)
d
    Frequently anxious, nervous, or 
worried
b
167 13.5 (10.9, 16.2) 713 7.1 (6.4, 7.7) 5.3 (2.8, 7.7)
Musculoskeletal
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Current asthma PD (95% Cl)
a
Yes No
Sample children Weighted population estimate Sample children Weighted population estimate
No. Percent (95% CI) No. Percent (95% CI)
    Lower back pain
b 97 7.8 (6.0, 9.7) 361 3.3 (2.8, 3.7) 3.8 (2.3, 5.3)
    Neck pain
b 70 6.7 (4.8, 8.6) 228 2.1 (1.8, 2.5) 4.3 (2.5, 6.1)
    Severe sprains or strains
b 82 7.5 (5.4, 9.5) 351 3.5 (3.1, 4.0) 3.4 (1.8, 4.9)
    Other chronic pain
b 21 1.5 (0.6, 2.3) 66 0.7 (0.5, 0.9) 0.7 (0.04, 1.4)
Neurological or cognitive
    Attention deficit hyperactivity 
disorder
185 14.8 (12.4, 17.2) 828 8.9 (8.2, 9.6)
4.5 (2.2, 6.7)
d
    Autism 28 1.8 (0.9, 2.6) 123 1.3 (1.0, 1.5) 0.6 (−0.01, 1.2)
    Diagnosed dizziness or balance 
problems
43 3.9 (2.7, 5.2) 149 1.6 (1.2, 1.9) 2.3 (1.3, 3.4)
    Frequent falls
b 45 3.6 (2.2, 4.9) 108 1.1 (0.8, 1.3) 2.8 (1.5, 4.1)
    Frequent headaches or migraines
b 145 12.2 (9.8, 14.6) 556 5.2 (4.7, 5.8) 5.6 (3.4, 7.8)
    Intellectual disability known as 
mental retardation
26 2.2 (1.2, 3.2) 105 1.1 (0.8, 1.3) 1.0 (0.2, 1.8)
    Learning disability 164 12.9 (10.6, 15.3) 712 7.4 (6.8, 8.1) 4.4 (2.1, 6.6)
    Other developmental delay 101 8.4 (6.4, 10.4) 422 4.5 (4.0, 5.0) 3.7 (1.7, 5.7)
    Vertigo
b 36 2.7 (1.5, 3.9) 135 1.4 (1.1, 1.7) 1.4 (0.4, 2.5)
Sleep and fatigue
    Excessive sleepiness during the 
day
b
154 7.4 (5.6, 9.3) 521 3.3 (2.9, 3.8) 3.6 (1.8, 5.4)
    Fatigue or lack of energy ≥3 days
b 90 13.6 (11.0, 16.2) 342 5.4 (4.8, 6.0) 7.8 (5.2, 10.3)
    Insomnia or trouble sleeping
b 132 12.0 (9.6, 14.4) 453 4.6 (4.0, 5.1) 6.6 (4.4, 8.9)
Vision
    Trouble seeing 65 5.9 (4.1, 7.6) 305 2.8 (2.4, 3.2) 2.9 (1.1, 4.7)
Voice, swallowing, speech, and 
language
    Diagnosed voice, swallowing, 
speech, or language problem
108 9.3 (7.2, 11.4) 442 5.1 (4.5, 5.6) 4.3 (2.2, 6.3)
    Stuttered/stammered
b 52 4.0 (2.6, 5.4) 172 1.7 (1.4, 2.0) 1.8 (0.7, 3.0)
Miscellaneous
    Anemia 29 2.1 (1.2, 2.9) 109 1.0 (0.8, 1.2) 1.3 (0.5, 2.1)
    Dental pain
b 120 9.9 (7.8, 12.1) 622 6.3 (5.7, 6.9) 3.0 (1.1, 4.9)
    Surgery or surgical procedure
b 82 6.8 (4.8, 8.7) 356 3.6 (3.1, 4.1) 3.3 (1.5, 5.0)
a
Adjusted for age, Hispanic ethnicity, parental educational attainment, race, and sex.
b
In the past 12 months.
c
Minor or definite/severe difficulty.
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d
Not adjusted for parental educational attainment due to model non-convergence.
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Table 3
Percentages of the weighted population estimate of children with current asthma with a reported asthma attack 
in the past 12 months or emergency department or urgent care center visit due to asthma in the past 12 months 
and associations with the number of comorbid conditions.
No. comorbidities Percent(SE) PD (95% CI)
a
Asthma attack
b 0 40.3 (4.3) 0.0 (referent)
1 46.1 (4.8) 4.7 (−7.3, 16.7)
2 50.0 (4.8) 8.0 (−3.7, 19.6)
3 58.3 (5.4) 12.1 (−2.0, 26.1)
4 47.9 (5.2) 5.2 (−8.2, 18.6)
5+ 68.2 (2.8) 29.2 (19.1, 39.2)
Emergency department or urgent care center visit due to asthma
b 0 11.5 (2.6) 0.0 (referent)
1 16.9 (3.6) 5.3 (−1.4, 12.1)
2 17.2 (3.8) 5.6 (0.2, 11.0)
3 20.5 (4.1) 6.4 (−1.2, 14.1)
4 17.3 (4.0) 6.6 (0.4, 12.8)
5+ 26.1 (2.5) 15.8 (9.9, 21.6)
a
Adjusted for age, Hispanic ethnicity, parental educational attainment, race, and sex.
b
In the past 12 months.
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